TCM Biotech International Corp.

NT$114.50As of Sun 8 Nov 2026, 12:00 UTC
TWSE:4169Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 16.55%
Div yield 0.31%
ROE (2.09%)
Biotechnology
Beta (5Y) 0.16
PE TTM —
TSR TTM (27.67%)
Mkt cap NT$7.606B
ROIC (5.92%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$138
20.28%
(86.13%)
Hold 5|7|11|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
2.02
2.05
2.18
2.17
39.78%
37.81%
31.75%
20.11%
RevenueNT$M
536.6
522.5
534.1
519.4
10.13%
7.52%
4.38%
(0.08%)
Peers (US$229.7M)
Cap (US$)
PE
229.6M
14.11x
Capital
TTM
5Y
10Y
Leveragex
1.361
0.057
0.050
EBIT/Intx
1.029
1.292
1.254
Own earn%
(80.85)
141.94
107.97
Sh yield%
11.53
28.17
34.52
Owners
Insiders/Inst%
5.73
24.14
Short interest%
4.57
SBC / revenue%
5.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
2–7
$1 testx
0.1
Incr. ROIC%
−1